Attitudes and beliefs among Georgia addiction treatment staff about medication for opioid use disorder in adolescents, young adults, and adults: a multi-mixed methods study

被引:2
|
作者
Welsh, Justine W. [1 ]
Mataczynski, Maggie J. [1 ]
Passetti, Lora L. [2 ]
Hunter, Brooke D. [2 ]
Godley, Mark D. [2 ]
机构
[1] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 12 Execut Pk Dr NE,Suite 200, Atlanta, GA 30329 USA
[2] Chestnut Hlth Syst, Normal, IL USA
来源
关键词
Adolescents; attitudes; beliefs; medication for opioid use disorder (MOUD); young adults; EXTENDED-RELEASE NALTREXONE; ASSISTED TREATMENT; BUPRENORPHINE-NALOXONE; DEPENDENT ADOLESCENTS; METHADONE; BARRIERS; STIGMA;
D O I
10.1080/00952990.2022.2043335
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Adverse consequences, including non-fatal overdose and death, are prevalent in adolescents and young adults with opioid use disorder (OUD). Barriers toward medication for opioid use disorder (MOUD) have been identified in adult populations but are poorly understood in youth. Objective This exploratory multi-mixed methods study examines beliefs and attitudes of addiction treatment program staff about the use of MOUD in youth. Methods A 40-item survey was distributed electronically to 299 addiction treatment programs in Georgia from May 2020 to January 2021. Participant (N = 215; 74% female) attitudes regarding the use of MOUD in three age groups (adolescents (aged 16-17), young adults (aged 18-25), and adults (aged 26+) on a 6-point Likert scale were compared using paired samples t-tests. A series of one-way ANOVA analyses examined differences in attitudes and beliefs across participant characteristics. Verbatim responses to qualitative survey questions were analyzed using a coding reliability approach to thematic analysis. Results Participants were less likely to support MOUD in adolescents (M = 3.68, SD 1.5) compared with young (M = 4.38, SD 1.36, t = 8.19, p < .001, d = .51) and older adults (M = 4.64, SD 1.3, t = 9.83, p < .001 d = .74). Participants endorsed higher response rates for the use of both naltrexone and buprenorphine over methadone in young adults. A total of 1,412 text responses were reviewed. Participants highlighted barriers to acceptance and use of MOUD in adolescents including safety concerns and impact on brain development. Conclusions The results support a comprehensive approach to reducing the barriers to using medications to treat OUDs in adolescent populations. Formal and focused continuing education to correct attitudes and beliefs about MOUD treatment for adolescents is necessary.
引用
收藏
页码:347 / 355
页数:9
相关论文
共 50 条
  • [31] A Mixed Methods Explanatory Study of Stigma, Sleep and Treatment Outcomes Among Individuals on Medication for Opioid Use Disorder presented by
    Nwanaji-Enwerem, Uzoji
    [J]. NURSING RESEARCH, 2021, 70 (03) : E144 - E144
  • [32] Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults
    Welsh, Justine W.
    Dennis, Michael L.
    Funk, Rodney
    Mataczynski, Maggie J.
    Godley, Mark D.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 132
  • [33] Assessing the Needs of Adolescents and Young Adults Receiving Cancer Treatment: A Mixed Methods Study
    Simon, Pamela J.
    Pyke-Grimm, Kimberly A.
    Nasr, Annette S.
    [J]. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2023, 12 (01) : 43 - 52
  • [34] USE OF BUPRENORPHINE FOR OPIOID USE DISORDER AMONG US ADOLESCENTS AND YOUNG ADULTS DURING THE COVID-19 PANDEMIC
    Alinsky, Rachel
    Prichett, Laura
    Chang, Hsien-Yen
    Alexander, G. Caleb
    Stein, Bradley
    Saloner, Brendan
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2022, 70 (04) : S16 - S16
  • [35] Medication Adherence among Adolescents and Young Adults living with Affective Disorder: a Qualitative Study in Russia and Denmark
    Cantarero-Arevalo, Lourdes
    Olsen, Sarah Fejfer
    Bakshinskayte, Maria Maria
    Hasoon, Zarah
    Mortensen, Nanna Nikoline Hvam
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 791 - 791
  • [36] Interest in Electronic Cigarettes for Smoking Cessation Among Adults With Opioid Use Disorder in Buprenorphine Treatment: A Mixed-Methods Investigation
    Streck, Joanna M.
    Regan, Susan
    Neil, Jordan
    Kalkhoran, Sara
    Gupta, Priya S.
    Bearnot, Benjamin
    Coker, Faith K.
    Kalagher, Kelly M.
    Park, Elyse
    Wakeman, Sarah
    Rigotti, Nancy A.
    [J]. NICOTINE & TOBACCO RESEARCH, 2022, 24 (07) : 1134 - 1138
  • [37] TRENDS IN RECEIPT OF BUPRENORPHINE AND NALTREXONE FOR OPIOID USE DISORDER AMONG ADOLESCENTS AND YOUNG ADULTS, 2000-2014
    Hadland, Scott Evan
    Wharam, J. Frank
    Schuster, Mark A.
    Zhang, Fang
    Samet, Jeffrey H.
    Larochelle, Marc R.
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2017, 60 (02) : S12 - S13
  • [38] Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014
    Hadland, Scott E.
    Wharam, J. Frank
    Schuster, Mark A.
    Zhang, Fang
    Samet, Jeffrey H.
    Larochelle, Marc R.
    [J]. JAMA PEDIATRICS, 2017, 171 (08) : 747 - 755
  • [39] PHYSICAL ACTIVITY BARRIERS AND FACILITATORS AMONG ADOLESCENTS AND YOUNG ADULTS WITH CANCER: A MIXED METHODS STUDY
    King-Dowling, Sara
    Nielsen, Kathryn
    Jankowski, Margaret
    Mitchell, Jonathan
    Psihogios, Alexandra
    Leahy, Allison Barz
    Devirgilio, Kristen
    Jubelirer, Tracey
    Schwartz, Lisa
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S451 - S451
  • [40] Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics
    Lynch, Victoria
    Clemans-Cope, Lisa
    [J]. SUBSTANCE USE & ADDICTION JOURNAL, 2024, 45 (03): : 434 - 445